Geneos Wealth Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $37.5K | Sell |
353
-57
| -14% | -$6.05K | ﹤0.01% | 1724 |
|
|
2025
Q1 | $127K | Buy |
410
+172
| +72% | +$53.4K | ﹤0.01% | 1433 |
|
|
2024
Q4 | $29.3K | Sell |
238
-8
| -3% | -$985 | ﹤0.01% | 1549 |
|
|
2024
Q3 | $27.4K | Buy |
246
+213
| +645% | +$23.7K | ﹤0.01% | 1433 |
|
|
2024
Q2 | $3.52K | Buy |
33
+2
| +6% | +$213 | ﹤0.01% | 1787 |
|
|
2024
Q1 | $3.73K | Hold |
31
| – | – | ﹤0.01% | 1774 |
|
|
2023
Q4 | $3.81K | Hold |
31
| – | – | ﹤0.01% | 1791 |
|
|
2023
Q3 | $4.01K | Hold |
31
| – | – | ﹤0.01% | 1805 |
|
|
2023
Q2 | $3.84K | Hold |
31
| – | – | ﹤0.01% | 1806 |
|
|
2023
Q1 | $4.54K | Hold |
31
| – | – | ﹤0.01% | 1756 |
|
|
2022
Q4 | $4.94K | Hold |
31
| – | – | ﹤0.01% | 1706 |
|
|
2022
Q3 | $4K | Sell |
31
-15
| -33% | -$1.94K | ﹤0.01% | 1740 |
|
|
2022
Q2 | $7K | Hold |
46
| – | – | ﹤0.01% | 2086 |
|
|
2022
Q1 | $7K | Sell |
46
-18
| -28% | -$2.74K | ﹤0.01% | 2226 |
|
|
2021
Q4 | $8K | Sell |
64
-172
| -73% | -$21.5K | ﹤0.01% | 2265 |
|
|
2021
Q3 | $30K | Sell |
236
-12
| -5% | -$1.53K | ﹤0.01% | 1724 |
|
|
2021
Q2 | $45K | Buy |
248
+46
| +23% | +$8.35K | ﹤0.01% | 1532 |
|
|
2021
Q1 | $33K | Hold |
202
| – | – | ﹤0.01% | 1830 |
|
|
2020
Q4 | $33K | Buy |
+202
| New | +$33K | ﹤0.01% | 1662 |
|
|
2016
Q4 | – | Sell |
-103
| Closed | -$12K | – | 2072 |
|
|
2016
Q3 | $12K | Buy |
103
+3
| +3% | +$350 | ﹤0.01% | 1307 |
|
|
2016
Q2 | $14K | Hold |
100
| – | – | ﹤0.01% | 1228 |
|
|
2016
Q1 | $13K | Buy |
+100
| New | +$13K | ﹤0.01% | 1221 |
|